Table 1 Patient and treatment characteristics
Characteristic | n (%) |
|---|---|
Sex | Â |
 Male | 59 (68.6) |
 Female | 27 (31.4) |
Age | Â |
 Median (IQR) | 60 (56–66) |
 Range | 21–83 |
Underlying disease | Â |
 DM | 5 (5.8) |
 HT | 23 (26.7) |
 HIV | 1 (1.2) |
Personal history | Â |
 Smoking |  |
  Never used | 21 (24.4) |
  Quit | 53 (61.6) |
 Use currently | 12 (14) |
 Alcohol |  |
  Never used | 31 (36) |
 Quit | 43 (50) |
  Using currently | 12 (14) |
 Chewing betel |  |
  Never | 75 (87.2) |
 Quit using | 5 (5.8) |
  Using currently | 6 (7) |
Oral status | Â |
 Oral hygiene |  |
  Excellent | 3 (3.5) |
 Good | 68 (79) |
  Fair | 12 (14) |
 Poor | 3 (3.5) |
 Edentulous gum | 16 (18.6) |
 Dental wearer | 9 (10.5) |
Tumor characteristics | Â |
 Tumor site |  |
  Nasopharynx | 37 (43) |
 Oropharynx | 25 (29.1) |
 Oral cavity | 24 (27.9) |
 T stage |  |
  T1 | 13 (15.1) |
 T2 | 18 (21) |
  T3 | 15 (17.4) |
 T4 | 40 (46.5) |
 N stage |  |
  N0 | 20 (23.3) |
 N1 | 19 (22.1) |
  N2 | 37 (43) |
 N3 | 10 (11.6) |
Radiotherapy | Â |
 Postoperative RT | 28 (32.6) |
 Radical RT | 58 (67.4) |
RT technique | Â |
 Conventional | 37 (43) |
 IMRT | 49 (57) |
RT dose | Â |
 Median (Gy) (IQR) | 70 (66–70) |
 Range | 20–70 |
Chemotherapy | Â |
 Concurrent chemotherapy | 67 (78) |
 No chemotherapy | 19 (22) |